Biotechnology Press Release
|04/30/2020 - 12:12||
Venture platform aims to build agritech start-ups
An initiative to launch companies in the food and agricultural science sector is being created by the Roslin Institute and investment firm Deep Science Ventures.
|04/30/2020 - 10:57||
2020 Graduates: URI student pairs doctoral research with completion of gigantic jigsaw puzzle
GSO doctoral student Rebecca Stevick’s research at URI examined the effect of environmental factors in Narragansett Bay had on oyster health and diseases and their associated microbial communities.
|University of R...|
|04/30/2020 - 10:01||
New antibody test will help state reopen
Researchers at the University of Minnesota Medical School have developed a test for antibodies to the SARS-CoV-2 virus—the agent that causes COVID-19—that uses routine laboratory supplies not in high demand.
|04/30/2020 - 09:45||
FBI Warns of Major Spike in Cyber Attacks
Domestic cyber criminals and nation-state attackers alike are capitalizing on this time of uncertainty – and remote workers are a prime target.
|04/30/2020 - 05:59||
UWA Expert Series - DNA may hold the key to protecting populations from COVID-19
Scientists from The University of Western Australia’s Faculty of Science are part of a global team that is developing a new DNA test for COVID-19, which can provide faster and more detailed results than other tests.
|04/30/2020 - 04:54||
Lincoln International Enhances Global Financial Sponsors Coverage with Hire of Florus Plantenga as Managing Director
Lincoln International, a global investment banking advisory firm, today announced the expansion of its global financial sponsors coverage capabilities with the addition of Florus Plantenga as a Managing Director who will be based in the firm’s London office.
|04/30/2020 - 00:38||
Compelling Data on Mechanism of Action for GlycoMimetics Late-stage Clinical Candidate Uproleselan Published in Nature Communications
The paper outlines how uproleselan, an investigational, first-in-class, targeted inhibitor of E-selectin, can reduce chemoresistance in acute myeloid leukemia (AML) through the key mechanism of targeted E-selectin inhibition.
|04/30/2020 - 00:35||
Magellan health and molina healthcare enter definitive
Magellan Health and Molina Healthcare Enter Into Definitive Agreements to Divest Magellan Complete Care and Establish Commercial Relationship for Multiple Magellan Services.
|04/29/2020 - 20:44||
AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand
The company continues to focus on the safety of its employees, assuring supply of critical raw materials, active pharmaceutical ingredients (API), and drug product, while seeking additional ways to assist in the significant prevention and treatment efforts needed to counter the spread of COVID-19.
|04/29/2020 - 19:38||
Scientists Have Discovered Drugs That Block Coronavirus, Paving Way for a Better Drug Sooner
Learn more about Gladstone's COVID-19 research projects and how science will overcome this pandemic.
|04/29/2020 - 14:51||
For Immediate Release Contact: Karen Kreeger kkreeger
DiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant to Profile Bitter Taste Blockers Collaboration Will Screen Human Taste Bud Cells with Small Molecule Libraries to Develop Easier Ways for Children and Adults to Take Bitter-Tasting Medications BIRMINGHAM, AL (April 29, 2020) – DiscoveryBioMed, Inc.
|04/29/2020 - 14:42||
Sandia scientists search for genetic bullet to battle COVID-19
LIVERMORE, Calf. — Two researchers at Sandia National Laboratories are using genetic resequencing tools to find a way to stop the COVID-19 pandemic in its tracks.
|04/29/2020 - 14:42||
DiscoveryBioMed and Monell Chemical Senses Center Awarded $1.68 Million Small Business Grant
Collaboration Will Screen Human Taste Bud Cells with Small Molecule Libraries to Develop Easier Ways for Children and Adults to Take Bitter-Tasting Medications.
|04/29/2020 - 14:19||
Antibodies from Llamas Could Help in Fight Against COVID-19
Scientists were inspired by antibodies produced by this llama, named Winter, to develop their antibody against SARS-CoV-2. Winter is four years old and still living on a farm in the Belgian countryside operated by Ghent University’s Vlaams Institute for Biotechnology.
|University of Texas|
|04/29/2020 - 13:43||
The Michael J. Fox Foundation Releases New Video Resource to Empower Patients and Families to Participate in Critical Parkinsons Research
New animated video, “Together, We Can Solve the Parkinson’s Puzzle,” aims to encourage Parkinson’s patients and families to take part in research to help speed a cure Narrated by Emmy- and Golden Globe-winning actor Alan Alda, the video can be watched at michaeljfox.org/your-role-research Content made possible by ACADIA Pharmaceuticals, with additional funding from members of MJFF’s Parkinson’s Disease Education Consortium.
|The Michael J. ...|
|04/29/2020 - 13:36||
Nanodevices for the brain could thwart formation of Alzheimers plaques
Alzheimer’s disease is the sixth leading cause of death in the United States, affecting one in people over the age of . Scientists are engineering nanodevices to disrupt processes in the brain that lead to the disease.
|04/29/2020 - 13:20||
Provectus Announces Acceptance of PV-10 Liver Cancer Abstracts at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
KNOXVILLE, TN, April 29, 2020 ( ) - Provectus (OTCQB: PVCT) today is pleased to announce that abstracts about and data from our clinical trials of investigational autolytic cancer immunotherapy PV-10 (rose bengal disodium) as a single-agent for the treatment of neuroendocrine tumors metastatic to the liver (NCT02693067) and in combination with immune checkpoint blockade for the treatment of uveal melanoma metastatic to the liver (NCT00986661) were accepted for the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, to be held May 29-31, 2020 online.
|04/29/2020 - 10:33||
Researchers measure cancer cell mechanics in living animals using nanoparticles
Contact(s): , Communications and Brand Strategy , A first-of-its-kind nanoparticle-based in vivo imaging technique that may one day be used to help diagnose and even treat cancer has been developed by researchers collaborating from Michigan State, Johns Hopkins and Stanford universities.
|Michigan State ...|
|04/29/2020 - 09:53||
Pharm-Olam recognized by 2020 CRO Leadership Awards second year in a row
HOUSTON, TX, April 29, 2020– Pharm-Olam, a leading mid-sized clinical research organization (CRO) serving the pharmaceutical and biotech industry, won multiple recognitions in Life Science Leader magazine’s 2020 CRO Leadership Awards.
|04/29/2020 - 09:35||
Finding COVID-19 Treatments in FDA-Approved Drugs for Rapid Repurposing
Senior Investigator Warner C. Greene, MD, PhD, wants to find COVID-19 treatments among the drugs already approved by the FDA, which would speed their use in the current pandemic.
|04/29/2020 - 08:40||
CRISPR-based diagnostic chips perform thousands of tests simultaneously to detect viruses
The diagnostic platform CARMEN combines microfluidics with the CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
|04/29/2020 - 04:22||
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate.
|04/29/2020 - 01:49||
Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL
Mumbai, Baltimore, April 29, 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials, from the United States Food and Drug Administration (U.S. FDA) to market a generic version of Brovana® Inhalation Solution, 15 mcg/2 mL of Sunovion Pharmaceuticals Inc.
|04/28/2020 - 14:34||
Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.
The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split.
|04/28/2020 - 14:21||
How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?
The Journal of Law, Medicine & Ethics April 28, 2020 Megan Robertson Megan Robertson, Associate in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, co-authored an article in The Journal of Law, Medicine & Ethics, titled “How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?”
|Epstein Becker Green|